Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Breztri in Chinese COPD Patients Post-Marketing Safety Study
CTR20211927Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Breztri Aerosphere in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Aug 2021; status: completed.
02
Drugs
Breztri Aerosphere
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20211927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211927.